There has been no news about Solid Biosciences (NASDAQ:SLDB) this morning so far but the stock has jumped by 8%. While there has been no news, it might be worthwhile for investors to take a look at a development from earlier in the week.
On June 7, the company, announced that it made an inducement offer to Dr. Iman Barilero, who had been appointed as its Chief Regulatory Officer not too long ago.
Solid Biosciences is a life sciences firm and is currently involved in advancing certain therapies that are meant for the treatment of Duchenne muscular dystrophy.
The majority of the independent directors at Solid Biosciences approved the inducement grant on May 5, 2021. The grant consists of an option to Dr. Barilero to pick up 180000 units of the Solid Biosciences common shares at the exercise price of $3.75 a share. The option can be exercised in a period spanning 10 years and in four instalments.
|+/- EMA(20)||4.02 (+3.73%)|
|+/- SMA(50)||4.60 (-9.35%)|
|+/- SMA(200)||5.00 (-16.60%)|
|CCI20||30.0907||Neutral||Chaikin Money Flow||-0.2443||Sell|
|MACD||-0.3618||Sell||Money Flow Index||58.6979||Buy|
|STOCH (14,3)||77.0492||Buy||STOCH RSI||1.0000||OverBought|